Related Experiment Video
Updated: Jun 20, 2025

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
Nonfungible Tokens in Cardiovascular Medicine
Solomon Bendayan1, Yossi Cohen1, Joshua Bendayan1
1Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Abstract:
The integration of nonfungible tokens (NFTs) in health care, particularly in cardiovascular medicine, represents a disruptive shift toward enhancing the security and interconnection of electronic health data around the patient. NFTs, unique digital certificates stored on a blockchain network, bind various sources of health data to their owner (the patient) and delineate the access rights for stakeholders (providers, researchers) using smart contracts. Data sources might include electronic medical records from different hospitals, clinics, pharmacies, test centres, and mHealth devices. Accordingly, patients and their providers benefit from seamless visibility of diagnoses, medications, electrocardiograms, imaging, home blood pressure logs, and artificial intelligence-enabled insights from these aggregated data. Rather than being stored on proprietary servers, data are encrypted and stored on decentralized networks with a unified point of access and immutable proof of ownership, making them more robust to theft or tampering. As custodians of their NFTs, patients are incentivized to actively partake in their health monitoring and self-driven research that aligns with their needs using innovative marketplaces that allow them to browse studies, document their informed consent, and monetize their contributions. Furthermore, they are empowered to educate themselves and seek care across siloes in traditional settings or virtual platforms such as the metaverse, where NFTs serve as digital passports. Despite these exciting prospects, adoption within the health care sector remains in its infancy, with ethical and technical limitations still being addressed. In this article we explore the multifaceted applications and key players in the field, and outline use-cases for patient-centred cardiovascular care featuring NFTs.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: β-Blockers
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Heart Failure Drugs: Diuretics

